Regeneron Pharmaceuticals, Inc.

VANGUARD GROUP INC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

9,075,153

Value ($000)

7,004,838

Weight

0.1%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	7,004,838	0.1%	9,075,153	12/31/2025
2025 Q3	11/7/2025	5,087,570	0.1%	9,048,269	9/30/2025
2025 Q2	8/11/2025	4,947,625	0.1%	9,424,048	6/30/2025
2025 Q1	5/9/2025	5,966,767	0.1%	9,407,891	3/31/2025
2024 Q4	2/11/2025	6,614,943	0.1%	9,286,346	12/31/2024
2024 Q3	11/13/2024	9,797,862	0.2%	9,320,290	9/30/2024
2024 Q2	8/13/2024	9,452,932	0.2%	8,993,970	6/30/2024
2024 Q1	5/10/2024	8,595,268	0.2%	8,930,241	3/31/2024
2023 Q4	3/11/2024	7,762,577	0.2%	8,838,285	12/31/2023
2023 Q3	12/18/2023	7,240,818	0.2%	8,798,505	9/30/2023
2023 Q2	8/14/2023	6,364,136	0.2%	8,857,038	6/30/2023
2023 Q1	7/14/2023	7,273,522	0.2%	8,852,121	3/31/2023
2022 Q4	2/10/2023	6,293,159	0.2%	8,722,448	12/31/2022
2022 Q3	11/14/2022	5,957,433	0.2%	8,648,125	9/30/2022
2022 Q2	8/12/2022	5,066,425	0.1%	8,570,745	6/30/2022
2022 Q1	5/13/2022	5,839,023	0.1%	8,360,330	3/31/2022
2021 Q4	2/14/2022	5,152,265	0.1%	8,158,515	12/31/2021
2021 Q3	11/12/2021	4,884,577	0.1%	8,071,281	9/30/2021
2021 Q2	8/13/2021	4,451,374	0.1%	7,969,660	6/30/2021
2021 Q1	5/14/2021	3,785,316	0.1%	8,000,412	3/31/2021
2020 Q4	2/12/2021	3,831,651	0.1%	7,931,220	12/31/2020
2020 Q3	11/16/2020	4,471,650	0.1%	7,988,228	9/30/2020
2020 Q2	8/14/2020	4,892,530	0.2%	7,844,995	6/30/2020
2020 Q1	5/15/2020	3,132,493	0.1%	6,415,230	3/31/2020
2019 Q4	2/14/2020	2,347,615	0.1%	6,252,303	12/31/2019
2014 Q2	8/11/2014	1,105,504	0.1%	3,913,703	6/30/2014
2014 Q1	5/13/2014	1,175,563	0.1%	3,914,889	3/31/2014
2013 Q4	2/12/2014	1,041,986	0.1%	3,785,730	12/31/2013